Formycon AG, Author at Formycon AG

What contribution can biosimilars make to reduce the burden on healthcare…

Another positive news at the turn of the year adds to our 2023 development…

Time to reflect, unwind, re-energize and enjoy - we wish you and your loved…

Together with our partners Polpharma Biologics, Bioeq AG and Teva Canada, we…

Formycon CEO Dr. Stefan Glombitza and CFO Enno Spillner will be present at the…

Another step towards providing a high-quality, safe and affordable treatment…

"Our latest MAA submission once again demonstrates the high performance and…

We are very much looking forward to the "Deutsches Eigenkapitalforum" (Equity…

Global Biosimilars Week 2023 highlights the strong impact of biosimilars once…

Formycon's corporate development is reflected in the very positive Q3 figures…